Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
36.70
+1.71 (4.89%)
At close: Jun 26, 2026, 4:00 PM EDT
37.32
+0.62 (1.69%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 594 employees as of December 31, 2025. The number of employees increased by 157 or 35.93% compared to the previous year.
Employees
594
Change (1Y)
157
Growth (1Y)
35.93%
Revenue / Employee
$30,419
Profits / Employee
-$835,670
Market Cap
3.87B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
CRNX News
- 10 days ago - Crinetics Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 13 days ago - Crinetics presents full results from Phase 2 trial of atumelnant - TheFly
- 13 days ago - Crinetics presents long-term data from program evaluating Palsonify - TheFly
- 13 days ago - Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control - GlobeNewsWire
- 17 days ago - Leerink sees favorable readthrough to Crinetics after Camurus’ Oclaiz CRL - TheFly
- 25 days ago - Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy' Initiative to Empower People Across Endocrine Disease Communities - GlobeNewsWire
- 26 days ago - Crinetics' Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026 - GlobeNewsWire